The U.S. government just approved a Saudi nuclear deal, expanding the global nuclear footprint at a time when defense spending is already at multi-decade highs. Lockheed and RTX just proved that the money is real — both posted record backlogs and jumped 7

Verdict: compelling thesis, but the trading rules just failed their final exam

The geopolitical thesis is real and well-supported: per the WSJ, the U.S. approved a Saudi nuclear deal on July 22, and Cameco's fundamentals genuinely confirm the demand narrative with revenue up 11.0% to $3.48B and free cash flow in the 94th percentile among Materials peers. But the systematic strategy built on this idea did not survive forward-testing — every parameter variant lost between -14.2% and -21.3% in the final 12-month holdout with win rates below 32%, and the research recommendation is explicitly no recommendation. The in-sample backtest looked strong (142% over 60 months on CCJ), yet a 52.1% maximum drawdown combined with the strategy's failure to generalize means you are trading a compelling macro story on rules that have not recently worked. LEU is the only name currently triggering an entry, but its own fundamentals are mixed — revenue grew just 1.5% year-over-year and its debt-to-equity of 1.54 is over ten times CCJ's 0.14. **Conviction breakdown:** Thesis support scores well given the concrete policy catalysts and CCJ's improving fundamentals. Backtest evidence is weighed down by universal out-of-sample losses across all variants. Fundamentals trend is solid for CCJ but undermined by LEU's weak growth and URA's negative aggregate net margin. Risk quality reflects the 52.1% historical drawdown and 96.7% annualized volatility on LEU. Trade readiness is moderate — only one of three names is currently in the entry zone.

Trade now

**LEU is the only ticker with a live entry today.** At $176.0, LEU sits above its 50-day exponential moving average ($173.3) with RSI at 61.1 — above 50 and below 70. All three entry conditions are met. Nearest resistance sits at $178.4, and the strategy's fixed take-profit at 4% would target roughly $183.0 against a hard stop at 2% unrealized loss (~$172.5). That floors your effective reward-to-risk at roughly 2:1. The broader backtest on this trend-confirmation approach produced a 142% return over 60 months across 238 trades with a 45.4% win rate, though the path included a 52.1% peak drawdown — size accordingly. **CCJ and URA are not yet in the entry zone.** CCJ at $88.5 is $10.3 below its 50-day EMA ($98.8) and needs to reclaim that level; RSI at 41.1 is 8.9 points shy of the 50 threshold. URA at $40.2 is $3.4 below its 50-day EMA ($43.6) with RSI at 47.1, still 2.9 points below the entry trigger. For both, "wait" is concrete: do nothing until price closes above the 50-day EMA and RSI pushes through 50 while staying under 70. No robust parameter setup was established — the walk-forward optimizer tested four EMA and RSI variants but the final 12-month holdout returned negative for every configuration, so the frozen baseline rules stand as published. Position sizing is capped at 25% of portfolio per name using a fixed-risk method keyed to a 78.6% Fibonacci stop, with a $100 minimum position value.

Why the bull case still has support

The thesis centers on geopolitical demand expanding the nuclear fuel market, and the fundamentals for Cameco (CCJ) — the largest suggested holding — genuinely support that narrative. CCJ grew revenue 11.0% year-over-year to $3.48B in fiscal 2025, but more importantly, that growth is translating into real cash: free cash flow hit $1.08B, landing in the 94th percentile among Materials-sector peers. Gross margin expanded to 27.9%, up from 25.0% the prior year and from essentially zero in 2021 — a trajectory that aligns with the idea's argument that rising uranium demand is finally flowing through to producer economics. Return on equity reached 8.5%, the highest in a decade for the company. The balance sheet is clean, with debt-to-equity at just 0.14, giving CCJ flexibility to ramp production if the Saudi deal and broader nuclear buildout materialize as the idea expects. The macro framing also has legs. Per the WSJ piece on July 22, the U.S. approved a Saudi nuclear deal — a concrete policy event that expands the addressable market for…

Scores

• Conviction score breakdown: 47
• Thesis support: 72
• Trade readiness: 45
• Risk quality: 32
• Backtest evidence: 28
• Fundamentals trend: 58

Watch items

• CCJ — Price vs 50-day EMA
• CCJ — RSI (14)
• CCJ — Price vs nearest support
• LEU — RSI (14)
• LEU — Price vs nearest resistance
• LEU — Price vs 50-day EMA
• URA — Price vs 50-day EMA
• URA — RSI (14)
• URA — Price vs nearest support
• CCJ — Price above EMA (50)
• CCJ — RSI (14) above 50
• CCJ — RSI (14) below 70